GI Oncology
News
Evidence Mounts for Aspirin's Anticancer Attributes
Major Finding: In a review of data from 51 studies, daily aspirin use reduced cancer deaths by 15% compared with no daily aspirin use, and reduced...
From the AGA Journals
Management of Zollinger-Ellison May Depend on Presence of Tumors
News
Evidence Mounts for Continuing Bevacizumab After Colorectal Cancer Progresses
Major Finding: Median progression-free survival was 4.9 months with second-line chemotherapy alone vs. 6.7 months with the addition of bevacizumab...
News
FDA Approves Aflibercept for Advanced Colorectal Cancer
News
Gefitinib Palliates Advanced Esophageal Cancer
Major Finding: Median overall survival was 3.73 months with gefitinib vs. 3.60 months with placebo (P = .285).Data Source: Data are from a phase...
News
Colorectal Surgery Complication Risk Factors Identified
Major Finding: Operating time had a significant impact on the outcomes of colorectal procedures.
News
Cetuximab Fails First-Line in Gastric Cancer
Major Findings: Median progression-free survival was 4.4 vs.
News
Less Liver Cancer in HCV Patients Given Antiviral Therapy
Major Finding: Antiviral therapy for hepatitis C carried a relative risk of 0.53 for developing hepatocellular carcinoma, compared with no...
News
Best Lynch Screening Strategy Identified
Major Finding: Universal screening of colorectal cancers’ DNA for MMR abnormalities had a sensitivity of 100% and a specificity of 93% in...
News
Gefitinib Offers Palliative Care in Advanced Esophageal Cancer
Major Finding: Median overall survival was 3.73 months with gefitinib vs. 3.60 months with placebo (P = .285).Data Source: Data are from a phase...